Nephrolithiasis. Current concepts in pathogenesis and management.
D000141:Acidosis, Renal Tubular / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000652:urine; D002951:Citrates / Q000627:therapeutic use; D003555:Cystinuria / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006863:Hydrogen-Ion Concentration; D006934:Hypercalcemia / Q000150:complications; D006961:Hyperparathyroidism / Q000601:surgery; D007239:Infections / Q000150:complications; D007410:Intestinal Diseases / Q000150:complications; D007669:Kidney Calculi / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D008277:Magnesium Oxide / Q000627:therapeutic use; D010396:Penicillamine / Q000008:administration & dosage / Q000627:therapeutic use; D010710:Phosphates / Q000627:therapeutic use; D012964:Sodium / Q000627:therapeutic use; D014527:Uric Acid / Q000652:urine
D002951:Citrates; D010710:Phosphates; D006852:Hydrochlorothiazide; D014527:Uric Acid; D008277:Magnesium Oxide; D012964:Sodium; D010396:Penicillamine